![]() Limit allergens in your environment : Keeping the windows closed and the air conditioning on to help limit the amount of pollen that gets into the home or car, especially on windy days, can make a difference.Getting ahead of it by giving the child their medicine, like a cromolyn nose spray a few days ahead of time, can help manage symptoms more effectively. For example, grass pollen season is in the spring and summer and the ragweed pollen season is in the late summer and early fall. Anticipating when your child may begin to react to allergens can help you get preventative medicine in place in enough time to keep the worst of the symptoms at bay. Know the seasons: Seasonal allergies are just that, seasonal.Vacuuming rugs and furniture is also helpful for dust mite allergies. Keeping it clean: Limiting where in the house pets may go and frequent vacuuming can help limit pet dander that can lead to an allergic reaction.Food for thought: Teaching your child from a young age what they are allergic to, what it looks like, what foods it may be found in and how to ask an adult to check food labels for them can help keep them from an allergic reaction.To reduce the risks presented by excess prescription medication, FDA has developed resources on safe drug disposal. Additionally, FDA is proactively working to address controlled substances illegally sold online. Protecting the Public from Unapproved, Diverted, or Counterfeit Drugs Presenting Overdose RisksįDA has developed resources on purchasing prescription medications online through BeSafeRx to help ensure access to medications from a safe source. Public Workshop on Practical Research Agenda for Treatment Development for Stimulant Use Disorder.Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder.A Research Agenda for Developing Stimulant Use Disorder Treatment.As there are currently no FDA-approved pharmacological treatments for stimulant use disorders, FDA is working to accelerate their development, including through public workshops and the publication of a meeting summary on research recommendations. FDA Hosts Public Workshop to Understand and Manage OverdoseĮvidence-Based Treatments for Stimulant Use DisordersįDA is supporting innovation in treatment development for stimulant use disorders.Information about Naloxone and Nalmefene.To aid this effort, FDA held a public workshop to inform product development and public health interventions to manage overdoses. Most fatal overdoses involving a stimulant also involve an opioid, and FDA has taken actions to help expand availability of life-saving opioid overdose reversal drugs. To accomplish this, FDA collaborates with federal partners to educate the public about the risks related to prescription stimulants, including side effects (e.g., anxiety, insomnia) and risk of addiction. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |